Use of docetaxel (Taxotere®) in patients with paclitaxel (Taxol®) hypersensitivity

被引：32
|
作者：
Moon, C [1 ]
Verschraegen, CF [1 ]
Bevers, M [1 ]
Freedman, R [1 ]
Kudelka, AP [1 ]
Kavanagh, JJ [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Internal Med Specialities, Sect Gynecol & Med Therapeut, Houston, TX 77030 USA
来源：
ANTI-CANCER DRUGS | 2000年 / 11卷 / 07期
关键词：
allergic reactions; ovarian neoplasms; taxane;
D O I：
10.1097/00001813-200008000-00007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Anaphylaxis or significant hypersensitivity reaction is one of the most catastrophic potential complications of chemotherapy. There is a 2-5% risk of hypersensitivity with paclitaxel, a commonly used chemotherapeutic agent for various cancers. Three patients, who developed hypersensitivity to paclitaxel infusion, received docetaxel without allergic reactions. Docetaxel may therefore be an alternative treatment for patients with paclitaxel hypersensitivity. [(C) 2000 Lippincott Williams & Wilkins].
引用
收藏
页码：565 / 568
页数：4
相关论文
共 50 条
  • [31] Docetaxel (Taxotere®) combined with trastuzumab (Herceptin)
    Ficorella, C
    TUMORI JOURNAL, 2001, 87 (01): : S10 - S18
  • [32] Docetaxel (Taxotere) and gemcitabine in combination therapy
    Rizvi, NA
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 19 - 22
  • [33] Docetaxel in the community setting:: An analysis of 377 breast cancer patients treated with docetaxel (Taxotere®) in the UK
    O'Brien, MER
    Leonard, RC
    Barrett-Lee, PJ
    Eggleton, SPH
    Bizzari, JP
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 205 - 210
  • [34] Docetaxel (Taxotere) in combination: A step forward
    Burris, HA
    Fields, S
    Peacock, N
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 35 - 40
  • [35] Docetaxel (Taxotere) administered in weekly schedules
    Greco, FA
    SEMINARS IN ONCOLOGY, 1999, 26 (03) : 28 - 31
  • [36] Falsely low pulse oximetry values in patients receiving docetaxel (Taxotere®)
    Paige, M
    Bickler, PE
    ANESTHESIA AND ANALGESIA, 2004, 99 (02): : 622 - 623
  • [37] Toxic dermatitis in patients treated with Taxotere® (docetaxel): three case reports
    van Oijen, B.
    Pleunis, M.
    Erdkamp, F.
    Prevoo, R.
    van der Kuy, H.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2011, 49 (01) : 46 - 48
  • [38] Peripheral neuropathy secondary to docetaxel (Taxotere)
    New, PZ
    Jackson, CE
    Rinaldi, D
    Burris, H
    Barohn, RJ
    NEUROLOGY, 1996, 46 (01) : 108 - 111
  • [39] Nail changes secondary to docetaxel (Taxotere)
    Correia, O
    Azevedo, C
    Ferreira, EP
    Cruz, FB
    Polónia, J
    DERMATOLOGY, 1999, 198 (03) : 288 - 290
  • [40] PHARMACOKINETICS AND METABOLISM OF TAXOTERE(TM) (DOCETAXEL)
    BRUNO, R
    SANDERINK, GJ
    CANCER SURVEYS, 1993, 17 : 305 - 313
12345